Digest Network Come funziona
Network
/
Società
Pa
Non verificato

Papillon Therapeutics Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIgiene alimentareIndustriaSalute

4 comunicati stampa

Guarda tutti i comunicati
21/10/2024
Industria
Biotecnologia
Farmaceutica
Salute
Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease
Fonte
Papillon Therapeutics Inc.
Emittente
Business Wire
1.00
0
15/10/2024
Industria
Igiene alimentare
HIV, AIDS e malattie autoimmuni
Salute
Biotecnologia
Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia
Fonte
Papillon Therapeutics Inc.
Emittente
Business Wire
1.00
0
01/10/2024
Industria
Salute
Igiene alimentare
Biologia
Biotecnologia
Medicina - Varie
Farmaceutica
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease
Fonte
Papillon Therapeutics Inc.
Emittente
Business Wire
1.00
0
17/09/2024
Igiene alimentare
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia
Fonte
Papillon Therapeutics Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0